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___________________________________________________________________________ 
Abstract:  The Monotheca A. DC. is a monotypic genus of the family Sapotaceae, which is widely distributed in 
Afghanistan, Djbouti, Northern Somalia, Oman, Pakistan and Southern Ethiopia. North-west Pakistan is the 
main region where Monotheca buxifolia (Falc.) A. DC., the only species of this genus, locally known as 
“Gurgura”, grows abundantly. It is an evergreen, fruit-producing medicinal tree. Bioassay-guided fractionation 
of the aerial parts of M. buxifolia afforded lupeol (1), lupeol acetate (2), betulin (3), oleanolic acid (4) and β-
amyrin (5) from the n-hexane and the chloroform fractions. This is the first report on the isolation, and 
identification of triterpenes (1-5) as the major compounds in the active fractions with antiproliferative property, 
and also on the antiproliferative activity of M. buxifolia extract and fractions against the human lung cancer cell 
line NCI-H460 in vitro. 
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1. Plant Source 
 
In continuation of our studies on medicinal plants from the Pakistani flora [1-3], Monotheca 
buxifolia (Falc.) A. DC. has been studied. In this short report, the isolation and identification of 
triterpenes (1-5) as the major compounds in the active fractions with antiproliferative property, and 
also the antiproliferative activity of M. buxifolia extract and fractions against the human lung cancer 
cell line NCI-H460 in vitro (Table 1) have been reported for the first time.  
 
The aerial parts of M. buxifolia (Falc.) A. DC. were collected during April 2011 from the Swat 
region in Pakistan. A voucher specimen representing this collection (GC Bot. Herb. 815) has been 
deposited in the Dr. Sultan Ahmed Herbarium, Department of Botany, GC University, Lahore, 
Pakistan. 
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2. Previous Studies 
 
Previous studies on this plant have demonstrated its antioxidant and antimicrobial properties 
[4, 5]. Whilst a report on the constituents of unsaponifiable fraction of the seed oils of M. buxifolia is 
available [6], to the best of our knowledge, there is no report on the isolation and identification of 
triterpenes from the aerial parts of this plant, as well as on the assessment of antiproliferative activity 
of the extracts, fractions and these compounds published to date. 
 
3. Present Study 
 
Shade-dried, ground aerial parts of M. buxifolia (4.2 kg) were macerated in methanol (MeOH, 
3 x 7 L) at room temperature and the pooled extract was concentrated by rotary evaporator under 
reduced pressure to yield 600 g of a gummy mass. This residue was suspended in water (400 mL) and 
successively partitioned with n-hexane (4 x 400 mL), chloroform (4 x 400 mL) and ethyl acetate 
(EtOAc, 4 x 400 mL) to obtain 150, 100 and 150 g of respective fractions. The n-hexane fraction was 
subjected to vacuum liquid chromatography (VLC) over silica gel using n-hexane-EtOAc as the 
solvent system in increasing order of polarity. The hexane sub-fraction 2, collected with n-
hexane:EtOAc (7:3) was re-chromatographed and eluted with n-hexane:EtOAc (7:3) to isolate 
compound 1 (10 mg). The sub-fraction 3, which was obtained with n-hexane:EtOAc (3:2), was re-
chromatographed over silica gel and eluted with n-hexane:EtOAc (3:2) to isolate compound 2 (8 mg). 
Similar chromatographic purification of the chloroform fraction afforded three other triterpenes (3-5) 
(Figure 1). Briefly, the chloroform fraction was loaded on silica gel column and eluted with n-hexane-
chloroform on increasing polarity resulting in three major sub-fractions 1-3. Fraction 1, which was 
eluted with n-hexane-chloroform (7:3) was further purified by column chromatography using n-
hexane-dichloromethane (1:1) as an eluent to afford compound 3 (13 mg). Sub-fraction 2, obtained 
with n-hexane-chloroform (6:4), was re-chromatographed over silica gel and eluted with n-hexane: 
dichloromethane (1:1) to afford compound 4 (30 mg). Sub-fraction 3, obtained from chloroform-
MeOH (19:1) solvent system, was purified by column chromatography using dichloromethane-MeOH 
(9:1) as an eluent to yield compound 5 (15 mg). Structures of the isolated compounds (1-5) were 
conclusively determined by spectroscopic analyses, mainly MS, and 1D and 2D NMR spectroscopy as 
well as by comparing their spectroscopic data with respective published literature data [7-11].  
 
Lupeol (1): White amorphous solid; melting point 215°C; EI-MS, HREI-MS 1H NMR (500 MHz, CD3OD) and 
13C NMR (125 MHz, CD3OD) data were in agreement with the published data [7]. 
Lupeol acetate (2): White greasy substance; melting point 214-216°C; EI-MS, HREI-MS 1H NMR (500 MHz, 
CD3OD) and 13C NMR (125 MHz, CD3OD) data were in agreement with the published data [8]. 
Betulin (3): White amorphous powder; melting point 217-219°C; EI-MS, HREI-MS 1H NMR (500 MHz, 
CD3OD) and 13C NMR (125 MHz, CD3OD) data were in agreement with the published data [9].  
Oleanolic acid (4): White powder; melting point 304-306°C; EI-MS, HREI-MS 1H NMR (500 MHz, CD3OD) 
and 13C NMR (125 MHz, CD3OD) data were in agreement with the published data [10].  
β-Amyrin (5): White amorphous solid; melting point 196-198°C; EI-MS, HREI-MS 1H NMR (500 MHz, 
CD3OD) and 13C NMR (125 MHz, CD3OD) data were in agreement with the published data [11].  
 
Whilst this is the first report on the occurrence of the triterpenes (1-5) in the genus Monotheca, 
other genera of the family Sapotaceae have been reported to produce these compounds [12-14]. 
 
Antiproliferative activity assay: The in vitro antiproliferative activity of the extract, fractions and 
isolated triterpenes (1-5) from M. buxifolia was assessed against the human lung cancer cell line NCI-
H460 using the sulforhodamine B assay [15]. The cells were cultured in Roswell Park Memorial 
Institute (RPMI) 1640 medium planted at a density of 5000 cell/well. Cells were washed with 
phosphate buffer saline (PBS) and detached with 0.025% trypsin-EDTA. The cell suspension was 
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made by adding 10 mL of RPMI 1640 solution and centrifuged for 10 min. Cells viability was counted 
in a haemocytometer, which exceeded 90% through trypan blue exclusion. Optimal seeding density of 
cell suspension was made after dilution and 100 μL of cell suspension was poured into 96-well plate, 
incubated at 37°C. The test extract (MeOH) and fractions (n-hexane, chloroform and EtOAc) were 
initially dissolved in DMSO and passed through a 0.2 μm filter. Five concentrations (1.0, 10, 50,100, 
250 μg/ mL) of all test samples were made by dilution in medium to determine the IC50 value. 
Similarly, five concentrations (0.1, 1.0, 5.0, 10, 50 μg/ mL) of each isolated triterpenes (1-5) were 
made along with the standard drugs doxorubicin and vinblastine as positive controls. Each 
concentration (100 μL) was added to well plates after 24 h of incubation. Cell growth was analyzed at 
the end of 72 h. After shaking plates for 20 min on a plate shaker, optical density was read at 570 nm. 
Percentage absorbance of test sample plates was compared to that of the control (non-treated cells) to 
investigate cell viability. The IC50 value of each test sample was calculated using the software 
WinNonLin Professional, Version 5.0.1.  
 
In the sulforhodamine B assay, amongst the test fractions, the n-hexane and the chloroform 
fractions showed the highest degree of activity with IC50 values of 59.2 and 46.1 µg/mL, respectively, 
and were subjected to further chromatographic analyses. All isolated triterpenes (1-5) exhibited 
considerable antiproliferative activity. Among them, oleanolic acid (5) was the most active with an 
IC50 value of 6.80 ± 1.73 μg/mL, which compares favourably to both positive controls, doxorubicin 
(IC50 = 10.5 ± 1.4 μg/mL) and vinblastine (IC50 = 8.13 ± 1.0 μg/mL) (Table 2). Lupeol (1), lupeol 
acetate (2), betulin (3) and β-amyrin (4) had the IC50 values, 19.2 ± 4.0, 63.4 ± 1.0, 79.2 ± 4.0 and 58.7 
± 2.0, respectively (Table 1). To the best of our knowledge, this is the first report on the 
antiproliferative activity of M. buxifolia. 
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Figure 1: Structures of triterpenes from M. buxifolia with antiproliferative property 
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This finding is in agreement with the previously reported potent antitumour activities of 
various triterpenes including lupeol (1), betulin (3) and oleanolic acid (5) [16-19]. The pentacyclic 
triterpene oleanolic acid (5) possesses a variety of pharmacological activities. Extensive studies on the 
synthesis of oleanolic acid (5) and its derivatives, and subsequent assessment of their anticancer 
potential have revealed their potential against various cancer cell lines [20]. Thus, the antiproliferative 
activity of the fractions was mainly owing to the presence of these well known bioactive compounds 
(1-5). It was suggested that the antiproliferative activity of these triterpenes might be linked to their 
ability to directly inhibit tumour growth cell cycle progression and induce apoptotic cell death by 
triggering the mitochondrial pathway of apoptosis [21]. Antiproliferative activities of triterpenes are 
also generally attributed to their complementary effects [22]. In Japan, oleanolic acid (5) is 
recommended for the treatment of skin cancer therapy [23]. Cosmetics preparation and medicinal 
formulations are patented comprising of oleanolic acid as active ingredient for topical use to treat skin 
cancer and oral use for curing non-lymphatic leukemia [24, 25]. Long term use of oleanolic acid >3 
months confirmed its safety for use, and a negligible side effects. Oleanolic acid has been used in 
health drinks and marketed in China for the treatment of liver disorders [26, 27]. 
 
In the present study, the elucidation of the antiproliferative activity of the MeOH extract and 
various fractions of M. buxifolia, and subsequent identification of bioactive compounds present in the 
active fractions and assessment of their antiproliferative potential have certainly identified this 
medicinal plant as a major source of antiproliferative compounds which could possibly be exploited 
commercially.   
 
Statistical analysis: Data were expressed as means ± standard error of the mean (SEM). The graph 
was plotted using non-linear regression with the use of GraphPad Prism version 6.0 for Windows 
(GraphPad Software, San Diego, CA, USA).  
 
Table 1: IC50 values of the extract, fractions and triterpenes from M. buxifolia against the 
human lung cancer cell line NCI-H460  
 
Test samples IC50 values (µg/mL) 
Methanol extract 172.0 ± 4.1 
n-Hexane fraction 59.2 ± 4.0 
Chloroform fraction 46.1 ± 2.0 
Ethyl acetate fraction 187.0 ± 1.1 
Lupeol (1) 63.4 ± 1.0 
Lupeol acetate (2) 80.4 ± 1.0 
Betulin (3) 79.2 ± 4.0 
β-amyrin (4) 58.7 ± 2.0 
Oleanolic acid (5) 6.8 ± 1.73 
Doxorubicin 10.5 ± 1.4 
Vinblastine 8.1 ± 1.0 
 
Acknowledgements 
The National Cancer Institute (NCI), USA, is thanked for provision of cancer cell lines NCI-H460, Dr. 
Khalid M. Khan (HEJ Research Institute of Chemistry, Karachi University, Pakistan) for NMR and 
MS spectral analysis, and Dr. Muhammad Ajaib, Plant Taxonomist, Department of Botany, GC 
University, Lahore, Pakistan, is thanked for plant sample identification and authentication. 
 
Author et al., Rec. Nat. Prod. (201X) X:X XX-XX  
 
 
309 
References 
[1]  A. I. Hussain , F. Anwar, P. S. Nigam, S. D. Sarker, J. E. Moore, J. R. Rao and A. Mazumdar (2011). 
Antibacterial activity of some Lamiaceae essential oils using resazurin as an indicator of cell growth, 
LWT – Food Sci. Technol. 44, 1199-1206. 
[2]  A. I .Hussain, F. Anwar, S. Rasheed, P. S. Nigam, O. Janneh and S. D. Sarker (2011). Composition and 
potential antibacterial, anticancer, antimalarial and antioxidant properties of the essential oils from two 
Origanum species growing in Pakistan, Braz. J. Pharmacog. 21, 943-952. 
[3]  A. I. Hussain, S. A. S. Chatha, F. Anwar, S. Latif, S.T.H Sherazi, A. Ahmad and S. D. Sarker (2013). 
Chemical composition and bioactivity studies of the essential oils from two Thymus species from the 
Pakistani flora, LWT – Food Sci. Technol. 50, 185-192. 
[4]  A. Hazrat, M. Nisar and S. Zaman (2013). Antibacterial activities of sixteen species of medicinal plants 
reported from Dir Kohistan valley park KPK, Pakistan, Pak. J. Bot. 45, 1369-1374. 
[5] S. Jan, M. R. Khan, M. Rashid and J. Bokhari (2013). Assessment of antioxidant potential, total phenolics 
and flavonoids of different solvent fractions of Monotheca Buxifolia fruit, Osong Public Health and Res. 
Perspectives 4, 246-254. 
[6] M. Nazir, J. U. Rehman, S. A. Khan and M. K. Bhatty (1986). The Constituents of unsaponifiable from 
Monotheca buxifolia seed oil, Fette, Seifen, Anstrichmittel.  88, 266-268.  
[7]     J. A. Blair, P. A. Ongley, J. Chiswell and M. H. G. Griffiths (1970). The isolation of lupeol from the bark 
of Heritiera utilis (Tarrietia utilis), Phytochem. 9, 671-675. 
[8]    R. A. Appleton and C. R. Enzell (1971). Triterpenoids and aromatic components of deertongue leaf, 
Phytochem. 10, 447–449. 
[9]     Y. Wu, J. Zhang, D. Wang, J. G. Liu and Y. Hu (2013). Triterpenoid Saponins from  Ziziphus jujuba var. 
spinose, Chem. Nat. Compds. 49, 677-681.  
[10] E. Catharina, S. Thabata, S. Santos, D. M. Marcelo, V. Filho, M. Auxiliadora and C. Kaplan (2013). 
Triterpene esters: natural products from Dorstenia arifolia (Moraceae), Molecules 18, 4247-4256. 
[11]    C. R. Liao, Y. H. Kuo, Y. L. Ho, C. Y. Wang , C. S. Yang, C. W. Lin and Y. S. Chang (2014). Studies on 
cytotoxic constituents from the leaves of Elaeagnus oldhamii Maxim. in non-small cell lung cancer A549 
cells, Molecules 19, 9515-9534. 
[12] J. Jahann, A. Malik, G. Mustafa, Z. Ahmad, S. Ahmad, E. Anis, S. Malik, S. Shujaat, N. Afza and A. U. 
Rahman (2001). Triterpenes from Mimusops elengi, Nat Prod Lett. 15, 177-185. 
[13]    N. M. Fayek, A. R. Monem, M.Y. Mossa, M. R. Meselhy and A. H. Shazly (2012). Chemical and 
biological study of Manilkara zapota (L.) Van Royen leaves (Sapotaceae) cultivated in Egypt, 
Pharmacog Res. 4, 85-91. 
[14]    N. M. Fayek, A. R. Monem, M. Y. Mossa and M. R. Meselhy (2013).  New triterpenoid acyl derivatives 
and biological study of Manilkara zapota (L.) Van Royen fruits, Pharmacog. Res, 5, 55-59. 
[15] V. Vichai and K. Kirtikara (2006). Sulforhodamine B colorimetric assay for cytotoxicity screening, Nat. 
Protoc. 1, 1112-1116. 
[16] M. Kondo (2006). Phytochemical  studies  of  extracts  of  cranberry  (Vaccinum macrocarpon) with  
anticancer,  antifungal  and  cardioprotective  properties, Masters Thesis, University of Massatuetts, 
Dartmouth. 
[17] C. A. Dehelean, C. Soica, I. Ledeto, M. Aluas, I. Zupko, A. Galuscan, S. Cinta-Pinzanu and M. Munteanu 
(2012). Study of the betulin enriched birch bark extracts effects on human carcinoma cells and ear 
inflammation, Chem. Central J. 6, 137-140. 
[18] M. Saleem (2009). Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene, Cancer Letts 
285, 109-115. 
[19] Y. Lee-Shan,  C. T. Tee,  S. P. Tan,  A. Khalijah,  M. H. Najihah,  A. N. Mohammad and A. Kartini 
(2014). Cytotoxic, antibacterial and antioxidant activity of triterpenoids from Kopsia singapuresis Ridl., 
J. Chem. Pharm. Res. 6, 815-822. 
[20] C. C. Neto (2011). Ursolic acid and other pentacyclic triterpenoids: anticancer activities and occurrence in 
berries, In ‘Berries and Cancer Prevention’, Eds. Stoner GD, Seeram NP., Springer, pp. 41-39. 
[21] S. Fulda (2008). Review: betulinic acid for cancer treatment and prevention, Int. J. Mol. Sci. 9, 1096-
1107. 
Running title 
 
 
310 
[22] A. M. Liberty, J. W. Amoroso, P. E. Hart and C. C. Neto (2009). Cranberry PACS and triterpenoids: 
anticancer activities in colon tumour cell lines.  Proceedings  of  Second  International Symposium  on  
Human  Health  Effects  of  Fruits  and  Vegetables,  Acta  Horticulturae 841, 61-66. 
[23] Y. Muto,  M. Ninomiya and H. Fujiki  (1990). Present status research on cancer chemoprevention in 
Japan.  Jap. J.  Clin.  Oncol. 20,  219-224. 
[24] Y. G. Liu (1986). Pharmaceutical composition for treating non-lymphatic leukemia and its components, 
Chem. Abst. 106, 90209j. 
[25] M. Ishida, T. Okubo, K. Koshimizu,  H. Daito, H. Tokuda, T. Kin, T. Yamamoto and N. Yamazaki 
(1990). Topical preparations  containing  ursolic  acid  and/or  oleanolic  acid for  prevention  of  skin  
cancer,  Chem. Abst. 113, 12173. 
[26] T. Okazaki, M. Suetsugu and T. Yoshida (1987). Hair tonics containing oleanolic acid derivatives.  Chem.  
Abst. 107,  P161369v. 
[27] T. Okudo, K. Koshimizu, H. Daito, B. Kin, K. Nishimoto and N. Yamazaki (1990). Health drinks 
containing ursolic acid and/or oleanolic acid,  Chem. Abst. 112, P54097m. 
 
 
 
 
© 2011 Reproduction is free for scientific studies 
 
 
